STOK logo

Stoke Therapeutics (STOK) Working Capital

Annual Working Capital

$184.52 M
-$28.16 M-13.24%

December 31, 2023


Summary


Performance

STOK Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSTOKbalance sheetmetrics:

Quarterly Working Capital

$203.75 M
-$48.75 M-19.31%

September 30, 2024


Summary


Performance

STOK Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSTOKbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

STOK Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.2%-0.5%
3 y3 years-34.7%-0.5%
5 y5 years+78.0%-0.5%

STOK Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-13.2%at low-28.0%+29.2%
5 y5-year-34.7%at low-28.0%+29.2%
alltimeall time-34.7%>+9999.0%-28.0%+108.0%

Stoke Therapeutics Working Capital History

DateAnnualQuarterly
Sep 2024
-
$203.75 M(-19.3%)
Jun 2024
-
$252.50 M(+60.1%)
Mar 2024
-
$157.69 M(-14.5%)
Dec 2023
$184.52 M(-13.2%)
$184.52 M(-9.9%)
Sep 2023
-
$204.82 M(-8.7%)
Jun 2023
-
$224.40 M(-6.0%)
Mar 2023
-
$238.71 M(+12.2%)
Dec 2022
$212.68 M(+0.3%)
$212.68 M(-9.8%)
Sep 2022
-
$235.81 M(-9.8%)
Jun 2022
-
$261.51 M(-7.5%)
Mar 2022
-
$282.87 M(+33.4%)
Dec 2021
$212.08 M
$212.08 M(-9.0%)
DateAnnualQuarterly
Sep 2021
-
$233.05 M(-7.5%)
Jun 2021
-
$252.04 M(-6.4%)
Mar 2021
-
$269.19 M(-4.7%)
Dec 2020
$282.50 M(+27.3%)
$282.50 M(+49.7%)
Sep 2020
-
$188.72 M(-5.5%)
Jun 2020
-
$199.74 M(-5.0%)
Mar 2020
-
$210.32 M(-5.2%)
Dec 2019
$221.93 M(+114.1%)
$221.93 M(-4.2%)
Sep 2019
-
$231.76 M(-3.3%)
Jun 2019
-
$239.63 M(+144.7%)
Mar 2019
-
$97.93 M(-5.5%)
Dec 2018
$103.68 M(-5843.8%)
$103.68 M
Dec 2017
-$1.80 M
-

FAQ

  • What is Stoke Therapeutics annual working capital?
  • What is the all time high annual working capital for Stoke Therapeutics?
  • What is Stoke Therapeutics annual working capital year-on-year change?
  • What is Stoke Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Stoke Therapeutics?
  • What is Stoke Therapeutics quarterly working capital year-on-year change?

What is Stoke Therapeutics annual working capital?

The current annual working capital of STOK is $184.52 M

What is the all time high annual working capital for Stoke Therapeutics?

Stoke Therapeutics all-time high annual working capital is $282.50 M

What is Stoke Therapeutics annual working capital year-on-year change?

Over the past year, STOK annual working capital has changed by -$28.16 M (-13.24%)

What is Stoke Therapeutics quarterly working capital?

The current quarterly working capital of STOK is $203.75 M

What is the all time high quarterly working capital for Stoke Therapeutics?

Stoke Therapeutics all-time high quarterly working capital is $282.87 M

What is Stoke Therapeutics quarterly working capital year-on-year change?

Over the past year, STOK quarterly working capital has changed by -$1.07 M (-0.52%)